MiMedx Group Inc
Change company Symbol lookup
Select an option...
MDXG MiMedx Group Inc
CATY Cathay General Bancorp
EADSF Airbus SE
ARAY Accuray Inc
TGI Triumph Group Inc
TSNP Tesoro Enterprises Inc
BLV Vanguard Long-Term Bond Index Fund ETF Shares
BP BP PLC
$RFTREES Refinitiv Eurozone ESG Select Index
DIV Global X SuperDividend™ U.S. ETF
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company's Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. Its biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. OrthoFlo is amniotic fluid-derived allograft for homologous use. Physio is a bone grafting material consists of bone tissue with no added carrier. CollaFix, its new brand, is its collagen fiber technology designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair.

Closing Price
$6.40
Day's Change
0.05 (0.79%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.64
Day's Low
6.35
Volume
(Light)
Volume:
43,698

10-day average volume:
73,332
43,698

Equitrans Midstream started at neutral with $11 stock price target at J.P. Morgan

6:32 am ET July 14, 2020 (MarketWatch)
Print

(END) Dow Jones Newswires

July 14, 2020 06:32 ET (10:32 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.